Effect of BIA 9-1067 at Steady-state on the Pharmacokinetics of Levodopa/Carbidopa and Levodopa/Benserazide

NCT01533116 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: BIA 9-1067
DRUG: Placebo
DRUG: levodopa/carbidopa
DRUG: levodopa/benserazide

Sponsor

Bial - Portela C S.A.